Modelling [Design Issues]

posted by mittyri – Russia, 2020-02-04 10:02 (1566 d 23:20 ago) – Posting: # 21140
Views: 3,110

Hi Helmut,

❝ ❝ B) Capture day 1 PK from time 0 to end of dosing interval, repeat dosing for x # of days (base on dosing interval) to hit SS. On last day of dosing capture time 0 - x (x = whatever hrs needed to fully capture the elimination phase + half-life).


❝ To characterize the PK of a new drug by PK modeling you would always go with this approach and sample as long as possible. Funky things may happen in nonlinear PK (auto-induction / -inhibition, capacity-limited elimination, …)


I don't think the proposed scheme is good enough for modelling such difficult things. There are no Ctau's planned. Moreover, I would mix the A and B for that purpose.

And sorry for a broken link, I cannot carve in my mind that tags for years :-D

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,643 registered users;
40 visitors (1 registered, 39 guests [including 6 identified bots]).
Forum time: 10:22 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5